Richard Whitley to Injections, Intravenous
This is a "connection" page, showing publications Richard Whitley has written about Injections, Intravenous.
Connection Strength
0.179
-
Herpes simplex virus infection. Semin Pediatr Infect Dis. 2002 Jan; 13(1):6-11.
Score: 0.051
-
A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med. 1991 Feb 14; 324(7):444-9.
Score: 0.024
-
Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009 Dec; 46 Suppl 4:S22-6.
Score: 0.022
-
Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation. Clin Pharmacol Ther. 2007 Jun; 81(6):867-72.
Score: 0.018
-
Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis. 2004 Nov 01; 39(9):1307-13.
Score: 0.015
-
Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals. Am J Med. 1982 Jul 20; 73(1A):165-71.
Score: 0.013
-
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001 Aug; 108(2):230-8.
Score: 0.012
-
Pharmacology, tolerance, and antiviral activity of vidarabine monophosphate in humans. Antimicrob Agents Chemother. 1980 Nov; 18(5):709-15.
Score: 0.012
-
Developmental aspects of adenine arabinoside for parenteral therapy of human herpesvirus infections. Adv Ophthalmol. 1979; 38:288-96.
Score: 0.010